Legal Representation
Attorney
Deborah J. Peckham
USPTO Deadlines
Next Deadline
37 days remaining
Non-Final Action Mailed
Due Date
September 11, 2025
Extension Available
Until December 11, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 11, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 11, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 11, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 27, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Conducting, arranging, promoting and organizing trade shows, business conferences, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations
First Use Anywhere:
Jun 5, 2020
First Use in Commerce:
Jun 5, 2020
Class 041
arranging and conducting trade shows, forums, meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing information and news in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing online, non-downloadable newsletters in the fields of pharmaceuticals, drug development, cell and gene therapy, drug manufacturing and drug regulations
First Use Anywhere:
Jun 5, 2020
First Use in Commerce:
Jun 5, 2020
Additional Information
Design Mark
The mark consists of a stylized "F" design in the color orange next to the words FIERCE PHARMA in a stylized font. No other colors are claimed as a feature of the mark.
Color Claim
The color(s) orange is/are claimed as a feature of the mark.
Pseudo Mark
FIERCE FIERCE PHARMA
Classification
International Classes
035
041